Aktis Oncology, Inc.
AKTS
$20.34
$1.226.38%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -21.05% | -24.29% | |||
| Total Depreciation and Amortization | -6.19% | 9.75% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 534.35% | -0.32% | |||
| Change in Net Operating Assets | -660.87% | -316.58% | |||
| Cash from Operations | -59.06% | -36.59% | |||
| Capital Expenditure | 55.37% | 15.07% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 118.31% | 123.99% | |||
| Cash from Investing | 116.24% | 122.58% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 131,609.30% | -23.08% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -119.71% | 72.28% | |||
| Cash from Financing | 43,823.70% | 74.06% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 334.33% | 111.25% | |||